Merck & Co Inc (NYSE:MRK) | Merck Announces Canadian Approval of GRASTEK® (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet)

[Business Wire] – Merck , known as MSD outside the United States and Canada, today announced the regulatory approval and launch of GRASTEK® sublingual tablets in . . . → Read More: Merck & Co Inc (NYSE:MRK) | Merck Announces Canadian Approval of GRASTEK® (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet) Similar Articles: Stock Update: Visa Inc. (NYSE:V) – Visa Inc. announces nomination of Alfred F. Kelly, Jr. and Maynard G. Webb, Jr. for election to the Board of Directors; Gary P. Coughlan announces decision not to stand for re-election in January Microsoft Corporation (NYSE:MSFT) | Microsoft spending $405 million on Windows marketing, aiming for 16 million tablet sales Microsoft Corporation (NYSE:MSFT) – Microsoft seeks EU approval for $7.5 bln Nokia deal